Cargando…
A preclinical model of peripheral T‐cell lymphoma GATA3 reveals DNA damage response pathway vulnerability
Peripheral T‐cell lymphoma (PTCL) represents a rare group of heterogeneous diseases in urgent need of effective treatments. A scarcity of disease‐relevant preclinical models hinders research advances. Here, we isolated a novel mouse (m)PTCL by serially transplanting a lymphoma from a germinal center...
Autores principales: | Kuczynski, Elizabeth A, Morlino, Giulia, Peter, Alison, Coenen‐Stass, Anna M L, Moss, Jennifer I, Wali, Neha, Delpuech, Oona, Reddy, Avinash, Solanki, Anisha, Sinclair, Charles, Calado, Dinis P, Carnevalli, Larissa S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174882/ https://www.ncbi.nlm.nih.gov/pubmed/35510955 http://dx.doi.org/10.15252/emmm.202215816 |
Ejemplares similares
-
Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity
por: Langdon, Sophie, et al.
Publicado: (2018) -
Longitudinal tracking of T cell lymphomas in mice using flow cytometry
por: Kuczynski, Elizabeth A., et al.
Publicado: (2023) -
PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8(+) T-cell activity
por: Carnevalli, Larissa S., et al.
Publicado: (2018) -
Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery
por: Taylor, Molly A., et al.
Publicado: (2019) -
Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program
por: Frye, Maike, et al.
Publicado: (2018)